CN Patent

CN101878229A — 用于治疗癌症的免疫脂质体

Assigned to Universitaetsspital Basel USB · Expires 2010-11-03 · 16y expired

What this patent protects

本发明涉及用于多重治疗罹患癌症、特别地由局部推进的或转移性肿瘤所代表癌症的人患者的免疫脂质体，并涉及在所述方法中使用的组合物。本发明还涉及免疫脂质体用于在癌症疗法中治疗多药抗性的用途。

USPTO Abstract

本发明涉及用于多重治疗罹患癌症、特别地由局部推进的或转移性肿瘤所代表癌症的人患者的免疫脂质体，并涉及在所述方法中使用的组合物。本发明还涉及免疫脂质体用于在癌症疗法中治疗多药抗性的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101878229A
Jurisdiction
CN
Classification
—
Expires
2010-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Universitaetsspital Basel USB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.